Predictors of suboptimal glycaemic control in type 2 diabetes patients: The role of medication adherence and body mass index in the relationship between glycaemia and age

2012 ◽  
Vol 96 (2) ◽  
pp. 119-128 ◽  
Author(s):  
Alexander Nagrebetsky ◽  
Simon Griffin ◽  
Ann Louise Kinmonth ◽  
Stephen Sutton ◽  
Anthea Craven ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Body Mass Index ◽  
Medication Adherence ◽  
Glycaemic Control ◽  
Body Mass ◽  
The Relationship ◽  
Diabetes Patients

The role of social support on the relationship of depressive symptoms to medication adherence and self-care activities in adults with type 2 diabetes

2015 ◽  
Vol 71 (9) ◽  
pp. 2164-2175 ◽  
Author(s):  
Chun-Ja Kim ◽  
Elizabeth A. Schlenk ◽  
Dae Jung Kim ◽  
Moonsun Kim ◽  
Judith A. Erlen ◽  
...  
Keyword(s):  
Social Support ◽  
Type 2 Diabetes ◽  
Depressive Symptoms ◽  
Medication Adherence ◽  
Self Care ◽  
Relationship Of ◽  
The Relationship

Adherence, body mass index, and depression in adults with type 2 diabetes: The mediational role of diabetes symptoms and self-efficacy.

2007 ◽  
Vol 26 (6) ◽  
pp. 693-700 ◽  
Author(s):  
William P. Sacco ◽  
Kristen J. Wells ◽  
Andrea Friedman ◽  
Rebecca Matthew ◽  
Sylvia Perez ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Body Mass Index ◽  
Body Mass ◽  
Self Efficacy ◽  
Mediational Role

The relationship among breakfast time, morningness-eveningness preference and body mass index in Type 2 diabetes

2018 ◽  
Vol 35 (7) ◽  
pp. 964-971 ◽  
Author(s):  
H. Nimitphong ◽  
N. Siwasaranond ◽  
S. Saetung ◽  
A. Thakkinstian ◽  
B. Ongphiphadhanakul ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Body Mass Index ◽  
Body Mass ◽  
The Relationship

scholarly journals A risk score including body mass index, glycated haemoglobin and triglycerides predicts future glycaemic control in people with type 2 diabetes

2017 ◽  
Vol 20 (3) ◽  
pp. 681-688 ◽  
Author(s):  
Dorijn F. L. Hertroijs ◽  
Arianne M. J. Elissen ◽  
Martijn C. G. J. Brouwers ◽  
Nicolaas C. Schaper ◽  
Sebastian Köhler ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Body Mass Index ◽  
Glycaemic Control ◽  
Body Mass ◽  
Risk Score ◽  
Glycated Haemoglobin

scholarly journals Circulating Nesfatin-1 Levels and Type 2 Diabetes: A Systematic Review and Meta-Analysis

2017 ◽  
Vol 2017 ◽  
pp. 1-8 ◽  
Author(s):  
Ting Zhai ◽  
Shi-Zhen Li ◽  
Xin-Tong Fan ◽  
Zhao Tian ◽  
Xiao-Qing Lu ◽  
...  
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Meta Analysis ◽  
Control Group ◽  
Newly Diagnosed ◽  
Antidiabetic Treatment ◽  
The Relationship ◽  
Diabetes Patients

The role of nesfatin-1 in glucose homeostasis has been investigated previously. However, although numerous studies have examined the relationships between circulating nesfatin-1 levels and type 2 diabetes, the conclusions are contradictory. We aimed to probe the relationship between circulating nesfatin-1 levels and type 2 diabetes by meta-analysis. Seven studies including 328 type 2 diabetes patients and 294 control subjects were included. Although there was no obvious difference in circulating nesfatin-1 levels between patients with type 2 diabetes and the control group (MD = −0.04; 95% CI = −0.32 to −0.23), subgroup analysis showed higher nesfatin-1 levels in newly diagnosed type 2 diabetes patients (MD = 0.59; 95% CI = 0.45 to 0.74) and significantly lower nesfatin-1 levels in type 2 diabetes patients receiving antidiabetic treatment (MD = −0.26; 95% CI = −0.33 to −0.20). In conclusion, the analysis supports a relationship between circulating nesfatin-1 levels and type 2 diabetes, where newly diagnosed type 2 diabetes was associated with an elevated Nesfatin-1 level, and type 2 diabetes patients receiving antidiabetic treatment showed lower circulating nesfatin-1 levels.

Sign in / Sign up

Export Citation Format

Share Document